Chief Operating Officer · AbCellera Biologics Inc. (ABCL)

Ph Véronique Lecault

FY2020 is the first fiscal year CompBrief holds for Ph Véronique Lecault as a named executive officer of AbCellera Biologics; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$5,950,539

Salary $196,533Stock awards $0Bonus $71,003

2nd of 3 named executive officers at AbCellera Biologics by FY2020 total.

3 named officers on file for AbCellera Biologics, FY2020

Ph Véronique Lecault’s pay file — $29

  • 1 fiscal year of pay, line by line
  • ABCL’s disclosed peer group of 20 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how AbCellera Biologics’s whole pay program stands against its peers

  • AbCellera Biologics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ABCL→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 28, 2021 (DEF 14A).

Free

Get Ph Véronique Lecault’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Ph Véronique Lecault compensation by year

AbCellera Biologics Summary Compensation Table · the one fiscal year held
In US dollars, as AbCellera Biologics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020
Salary$196,533
Bonus$71,003
Stock awards$0
Option awards$5,683,003
Non-equity incentive$0
Pension and deferred compensation$0
All other$0
Total$5,950,539

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: AbCellera Biologics Inc. DEF 14A filed April 28, 2021, accession 0001140361-21-014738, and prior-year filings. Open the filing on EDGAR.

How this page was built: the AbCellera Biologics Inc. filed document, accession 0001140361-21-014738. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2021.

AbCellera Biologics’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Carl HansenChief Executive Officer$16,962,608
Ph Véronique Lecault · this pageChief Operating Officer$5,950,539
Tryn StimartChief Legal Officer , Chief Compliance Officer & Corporate Secretary$4,434,343

Board service

AbCellera Biologics board · FY2024–FY2025

How this board is paid

Company policy: AbCellera Biologics pays directors a $50,000 cash retainer and $400,000 in Options. As stated in AbCellera Biologics's FY2025 proxy.

The full AbCellera Biologics compensation record

free company brief

This page is one person within AbCellera Biologics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are AbCellera Biologics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Ph Véronique Lecault's compensation dossier · One-time report. No refunds.